Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stroke

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 210 articles: HTML format Text format

Single Articles

August 2018
1. FISCHER Q, Georges JL, Le Feuvre C, Sharma A, et al
   Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
   Int J Cardiol. 2018;264:64-69.
   PubMed     Text format     Abstract available
   
   
   July 2018
2. VEDOVATI MC, Giustozzi M, Verdecchia P, Pierpaoli L, et al
   Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study.
   Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)32719.
   PubMed     Text format     Abstract available
   
   
   
3. RIVA L, Ageno W, Di Pasquale G, Agnelli G, et al
   Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism.
   Int J Cardiol. 2018 Jul 26. pii: S0167-5273(18)32356.
   PubMed     Text format     Abstract available
   
   
   
4. KOBAYASHI N, Hata N, Tsurumi M, Shibata Y, et al
   Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to preinfarction angina in patients with acute myocardial infarction.
   Int J Cardiol. 2018 Jul 18. pii: S0167-5273(18)32180.
   PubMed     Text format     Abstract available
   
   
   
5. BURLACU A, Covic A
   'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation.
   Int J Cardiol. 2018;262:43-44.
   PubMed     Text format    
   
   
   June 2018
6. SPOSATO LA, Lopes RD
   Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice.
   Int J Cardiol. 2018;261:99-100.
   PubMed     Text format    
   
   
   
7. PARASKEVAS KI, Naylor AR
   Carotid artery stenosis at the time of coronary artery bypass grafting is a risk factor but not a cause for peri-operative stroke.
   Int J Cardiol. 2018;260:23.
   PubMed     Text format    
   
   
   May 2018
8. VISZLAYOVA D, Brozman M, Langova K, Herzig R, et al
   Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trial.
   Int J Cardiol. 2018 May 26. pii: S0167-5273(18)30634.
   PubMed     Text format     Abstract available
   
   
   
9. SCHOOLING CM, Luo S, Au Yeung SL, Thompson DJ, et al
   Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation.
   Int J Cardiol. 2018 May 18. pii: S0167-5273(17)36101.
   PubMed     Text format     Abstract available
   
   
   April 2018
10. SHENG X, Ding S, Ge H, Sun Y, et al
    Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
    Int J Cardiol. 2018 Apr 25. pii: S0167-5273(17)37021.
    PubMed     Text format     Abstract available
    
    
    
11. BAI J, Shen D, Wang B, Han Q, et al
    Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
    Int J Cardiol. 2018;257:226.
    PubMed     Text format    
    
    
    
12. LI B, Sun C, Qin F, Liu N, et al
    Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
    Int J Cardiol. 2018;256:39.
    PubMed     Text format    
    
    
    March 2018
13. MUJOVIC N, Potpara TS
    Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
    Int J Cardiol. 2018;254:164-166.
    PubMed     Text format    
    
    
    February 2018
14. GOETTE A
    Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
    Int J Cardiol. 2018;253:82-83.
    PubMed     Text format    
    
    
    
15. FAUCHIER L, Bisson A, Genet T
    Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
    Int J Cardiol. 2018;252:110-111.
    PubMed     Text format    
    
    
    January 2018
16. JOLOBE OMP
    Proposed rationale for anticoagulants in nonvalvular atrial fibrillation with zero CHA2DS2-Vasc score.
    Int J Cardiol. 2018 Jan 21. pii: S0167-5273(17)36194.
    PubMed     Text format    
    
    
    
17. QIN F, Liu N, Liu C, Bai F, et al
    Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
    Int J Cardiol. 2018;251:53.
    PubMed     Text format    
    
    
    
18. BAI R
    Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
    Int J Cardiol. 2018;251:51-52.
    PubMed     Text format    
    
    
    
19. FERLINI M, Rossini R
    Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage.
    Int J Cardiol. 2018;251:42-44.
    PubMed     Text format     Abstract available
    
    
    
20. WAKABAYASHI K, Ikeda N, Kajimoto K, Minami Y, et al
    Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure.
    Int J Cardiol. 2018;250:164-170.
    PubMed     Text format     Abstract available
    
    
    December 2017
21. WONG CX
    Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
    Int J Cardiol. 2017;249:260.
    PubMed     Text format    
    
    
    
22. CERIT L
    Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
    Int J Cardiol. 2017;249:259.
    PubMed     Text format    
    
    
    
23. GOETTE A
    Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
    Int J Cardiol. 2017;249:247-248.
    PubMed     Text format    
    
    
    November 2017
24. MAKOWSKI M, Baj Z
    New biomarkers in risk stratification in patients with atrial fibrillation.
    Int J Cardiol. 2017;247:19.
    PubMed     Text format    
    
    
    
25. BARKAS F, Elisaf M, Liberopoulos E
    Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
    Int J Cardiol. 2017;247:18.
    PubMed     Text format    
    
    
    
26. QIN F, Zhao Y, He B, Liu Q, et al
    Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
    Int J Cardiol. 2017;247:17.
    PubMed     Text format    
    
    
    
27. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
    Int J Cardiol. 2017;246:53.
    PubMed     Text format    
    
    
    October 2017
28. WIYEH AB, Ochodo EA, Wiysonge CS, Kakia A, et al
    A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion.
    Int J Cardiol. 2017 Oct 26. pii: S0167-5273(17)35919.
    PubMed     Text format     Abstract available
    
    
    
29. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
    Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
    Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
    PubMed     Text format     Abstract available
    
    
    
30. TSE G, Lip GYH, Liu T
    The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
    Int J Cardiol. 2017;245:181-182.
    PubMed     Text format    
    
    
    
31. WANG S, Li J, Yan G, Zhang Y, et al
    New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
    Int J Cardiol. 2017;244:296.
    PubMed     Text format    
    
    
    September 2017
32. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
    Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
    PubMed     Text format     Abstract available
    
    
    
33. SAMBOLA A, Ruiz-Meana M, Barba I, Del Blanco BG, et al
    Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2017;243:9-14.
    PubMed     Text format     Abstract available
    
    
    
34. TOCCI G, Presta V
    Increased arterial stiffness and haemorrhagic transformation in ischaemic stroke after thrombolysis: A new marker of risk for cerebrovascular events and complications.
    Int J Cardiol. 2017;243:471-472.
    PubMed     Text format    
    
    
    
35. ACAMPA M, Camarri S, Lazzerini PE, Guideri F, et al
    Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis.
    Int J Cardiol. 2017;243:466-470.
    PubMed     Text format     Abstract available
    
    
    
36. AYUBI E, Safiri S
    Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
    Int J Cardiol. 2017;242:9.
    PubMed     Text format    
    
    
    
37. HU WS, Lin CL
    Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017;242:10.
    PubMed     Text format    
    
    
    August 2017
38. GLOEKLER S, Saw J, Koskinas KC, Kleinecke C, et al
    Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)33620.
    PubMed     Text format     Abstract available
    
    
    July 2017
39. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available
    
    
    
40. ROSSELLO X, Huo Y, Pocock S, de Werf FV, et al
    Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.
    Int J Cardiol. 2017 Jul 15. pii: S0167-5273(17)32845.
    PubMed     Text format     Abstract available
    
    
    
41. CERIT L
    Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
    Int J Cardiol. 2017;239:22.
    PubMed     Text format    
    
    
    
42. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
    Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
    PubMed     Text format     Abstract available
    
    
    June 2017
43. LAVI S, Iqbal J, Cairns JA, Cantor WJ, et al
    Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial.
    Int J Cardiol. 2017 Jun 29. pii: S0167-5273(17)33508.
    PubMed     Text format     Abstract available
    
    
    
44. VIDALE S, Arnaboldi M, Bosio V, Corrado G, et al
    Short-term air pollution exposure and cardiovascular events: A 10-year study in the urban area of Como, Italy.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)31683.
    PubMed     Text format     Abstract available
    
    
    
45. CAPPELLARI M, Bovi P
    Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32629.
    PubMed     Text format     Abstract available
    
    
    
46. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
    Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
    PubMed     Text format     Abstract available
    
    
    
47. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
    Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
    Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
    PubMed     Text format     Abstract available
    
    
    
48. CARMO J, Ferreira J, Costa F, Carmo P, et al
    Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
    PubMed     Text format     Abstract available
    
    
    
49. ACHILLES A, Mohring A, Dannenberg L, Piayda K, et al
    Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.
    Int J Cardiol. 2017;236:76-81.
    PubMed     Text format     Abstract available
    
    
    
50. MEFFORD M, Safford MM, Muntner P, Durant RW, et al
    Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.
    Int J Cardiol. 2017;236:462-465.
    PubMed     Text format     Abstract available
    
    
    
51. CHAIKRIANGKRAI K, Jhun HY, Palamaner Subash Shantha G, Bin Abdulhak A, et al
    Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis.
    Int J Cardiol. 2017;236:473-477.
    PubMed     Text format     Abstract available
    
    
    May 2017
52. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
    Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
    PubMed     Text format     Abstract available
    
    
    
53. BECATTINI C, Franco L, Agnelli G
    Risk of death in patients with major bleedings while on treatment with oral anticoagulants.
    Int J Cardiol. 2017;235:200.
    PubMed     Text format    
    
    
    
54. ALEXOPOULOS D
    Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017;234:131.
    PubMed     Text format    
    
    
    
55. SUZUKI M, Takanashi S
    Assessment of clinical severity in patients with infective endocarditis with cardio-embolic strokes.
    Int J Cardiol. 2017;234:140.
    PubMed     Text format    
    
    
    April 2017
56. KWOK CS, Bagur R, Rashid M, Lavi R, et al
    Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34897.
    PubMed     Text format     Abstract available
    
    
    March 2017
57. SHEN L, Song L, Liu B, Li H, et al
    Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women.
    Int J Cardiol. 2017 Mar 30. pii: S0167-5273(16)33287.
    PubMed     Text format     Abstract available
    
    
    
58. KAIER K, Reinecke H, Schmoor C, Frankenstein L, et al
    Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study.
    Int J Cardiol. 2017 Mar 2. pii: S0167-5273(17)31288.
    PubMed     Text format     Abstract available
    
    
    
59. KLAER J, Mahler A, Scherbakov N, Klug L, et al
    Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study.
    Int J Cardiol. 2017;230:241-247.
    PubMed     Text format     Abstract available
    
    
    February 2017
60. PROIETTI M, Lip GY
    Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(17)30411.
    PubMed     Text format     Abstract available
    
    
    
61. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population.
    Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)34726.
    PubMed     Text format     Abstract available
    
    
    
62. GUIMARAES LF, Stone GW, Caixeta A
    Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017 Feb 11. pii: S0167-5273(17)30775.
    PubMed     Text format    
    
    
    
63. MASUDA K, Ishizu T, Niwa K, Takechi F, et al
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.
    Int J Cardiol. 2017 Feb 5. pii: S0167-5273(17)30680.
    PubMed     Text format     Abstract available
    
    
    
64. MODI R, Patted SV, Halkati PC, Porwal S, et al
    CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
    Int J Cardiol. 2017;228:1002-1006.
    PubMed     Text format     Abstract available
    
    
    
65. YUAN X, Du J, Liu Q, Zhang L, et al
    Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
    Int J Cardiol. 2017;228:958-966.
    PubMed     Text format     Abstract available
    
    
    January 2017
66. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
    Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
    PubMed     Text format     Abstract available
    
    
    
67. KO D, Thigpen JL, Otis JA, Forster K, et al
    Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
    Int J Cardiol. 2017;227:808-812.
    PubMed     Text format     Abstract available
    
    
    
68. SUZUKI M, Takanashi S, Ohshima Y, Nagatomo Y, et al
    Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes.
    Int J Cardiol. 2017;227:222-224.
    PubMed     Text format     Abstract available
    
    
    December 2016
69. GUIMARAES LF, Genereux P, Silveira D, Pesaro AE, et al
    P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34824.
    PubMed     Text format     Abstract available
    
    
    
70. MUSCOGIURI G, Annweiler C, Duval G, Karras S, et al
    Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke.
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34541.
    PubMed     Text format     Abstract available
    
    
    
71. KAHLERT P, Hildebrandt HA, Patsalis PC, Al-Rashid F, et al
    No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)33752.
    PubMed     Text format     Abstract available
    
    
    November 2016
72. LEE CH, Lin TY, Chang SH, Chen CH, et al
    Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
    Int J Cardiol. 2016;228:771-778.
    PubMed     Text format     Abstract available
    
    
    
73. WYBRANIEC MT, Faryan M, Kusz B, Lasek-Bal A, et al
    CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischaemic stroke.
    Int J Cardiol. 2016;228:286-288.
    PubMed     Text format    
    
    
    
74. WONG CK
    Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons.
    Int J Cardiol. 2016;227:30-36.
    PubMed     Text format     Abstract available
    
    
    
75. SASAI M, Iso Y, Mizukami T, Tomosugi N, et al
    Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
    Int J Cardiol. 2016;227:114-121.
    PubMed     Text format     Abstract available
    
    
    
76. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available
    
    
    
77. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available
    
    
    
78. ZHU W, Fu L, Ding Y, Huang L, et al
    Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33445.
    PubMed     Text format     Abstract available
    
    
    
79. GUIMARAES PO, Wojdyla DM, Alexander JH, Thomas L, et al
    Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33444.
    PubMed     Text format     Abstract available
    
    
    October 2016
80. NAVARESE EP, Kolodziejczak M, Winter MP, Alimohammad A, et al
    Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33272.
    PubMed     Text format     Abstract available
    
    
    September 2016
81. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available
    
    
    
82. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available
    
    
    
83. RUSSO V, Di Napoli L, Bianchi V, Tavoletta V, et al
    A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
    Int J Cardiol. 2016;224:454-455.
    PubMed     Text format    
    
    
    
84. INDRARATNA P, Tian DH, Yan TD, Doyle MP, et al
    Transcatheter aortic valve implantation versus surgical aortic valve replacement: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;224:382-387.
    PubMed     Text format     Abstract available
    
    
    
85. AKCAY M, Soylu K, Yanik A
    Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA.
    Int J Cardiol. 2016;224:265-266.
    PubMed     Text format    
    
    
    
86. TAKEUCHI D, Inai K, Shinohara T, Nakanishi T, et al
    Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
    Int J Cardiol. 2016;224:139-144.
    PubMed     Text format     Abstract available
    
    
    August 2016
87. KATZ M, Bosworth HB, Lopes RD, Dupre ME, et al
    A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade.
    Int J Cardiol. 2016;224:33-36.
    PubMed     Text format     Abstract available
    
    
    
88. DZIEWIERZ A, Siudak Z, Tokarek T, Rakowski T, et al
    Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry).
    Int J Cardiol. 2016;223:236-238.
    PubMed     Text format    
    
    
    
89. SANI M, Ayubi E, Mansori K, Khazaei S, et al
    Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
    Int J Cardiol. 2016;222:949.
    PubMed     Text format    
    
    
    
90. HUMBERT X, Roule V, Chequel M, Fedrizzi S, et al
    Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
    Int J Cardiol. 2016 Aug 4. pii: S0167-5273(16)31605.
    PubMed     Text format     Abstract available
    
    
    
91. HUGO GS, Figueiras-Graillet LM, Anguita M, Marin F, et al
    Oral anticoagulation in octogenarians with atrial fibrillation.
    Int J Cardiol. 2016;223:87-90.
    PubMed     Text format     Abstract available
    
    
    
92. BEDEIR K, Giugliano RP, Ramlawi B
    Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
    Int J Cardiol. 2016;222:615-619.
    PubMed     Text format     Abstract available
    
    
    
93. KIM Y, Lee SH
    Embolic stroke and after-admission atrial fibrillation.
    Int J Cardiol. 2016;222:576-580.
    PubMed     Text format     Abstract available
    
    
    
94. ERGUN G, Basaran O, Dogan V, Dogan MM, et al
    Obesity and atrial fibrillation.
    Int J Cardiol. 2016;223:159-160.
    PubMed     Text format    
    
    
    
95. ELGENDY IY, Mahmoud AN, Mansoor H, Mojadidi MK, et al
    Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?
    Int J Cardiol. 2016;222:441-447.
    PubMed     Text format     Abstract available
    
    
    
96. CANOY D, Cairns BJ, Balkwill A, Wright FL, et al
    Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort.
    Int J Cardiol. 2016;222:1012-1018.
    PubMed     Text format     Abstract available
    
    
    July 2016
97. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study.
    Int J Cardiol. 2016;222:281-286.
    PubMed     Text format     Abstract available
    
    
    
98. PATZER J, Oqab Z, McIntyre WF, Hopman WM, et al
    Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients.
    Int J Cardiol. 2016;223:63-64.
    PubMed     Text format    
    
    
    
99. ENGDAHL J, Holmen A, Svennberg E, Friberg L, et al
    Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.
    Int J Cardiol. 2016;222:430-435.
    PubMed     Text format     Abstract available
    
    
    
100. GARG L, Chen C, Haines DE
     Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
     Int J Cardiol. 2016;222:47-50.
     PubMed     Text format     Abstract available
     
     
     
101. SENOO K, Lip GY
     Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
     Int J Cardiol. 2016;221:379-382.
     PubMed     Text format     Abstract available
     
     
     June 2016
102. PAGNESI M, Martino EA, Chiarito M, Mangieri A, et al
     Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
     Int J Cardiol. 2016;221:97-106.
     PubMed     Text format     Abstract available
     
     
     
103. CHOI EJ, Lee IH, Je NK
     Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
     Int J Cardiol. 2016;220:647-652.
     PubMed     Text format     Abstract available
     
     
     
104. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
     Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
     PubMed     Text format     Abstract available
     
     
     
105. XIA SJ, Du X, Li C, Wu JH, et al
     Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
     Int J Cardiol. 2016;220:284-289.
     PubMed     Text format     Abstract available
     
     
     
106. ROKOS J, Heger M, Stollberger C, Finsterer J, et al
     Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban.
     Int J Cardiol. 2016;221:383-384.
     PubMed     Text format    
     
     
     
107. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
     Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
     Int J Cardiol. 2016;219:251-256.
     PubMed     Text format     Abstract available
     
     
     
108. COLANTONIO LD, Gamboa CM, Kleindorfer DO, Carson AP, et al
     Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
     Int J Cardiol. 2016;220:122-128.
     PubMed     Text format     Abstract available
     
     
     May 2016
109. TONG Y, Cai L, Zhang YW, Lin L, et al
     Role of functional polymorphisms of the IL-10 gene promoter in the risk of ischemic stroke in Chinese Uyghur population: One case-control study.
     Int J Cardiol. 2016;211:58-60.
     PubMed     Text format    
     
     
     April 2016
110. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
     ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
     Int J Cardiol. 2016;217:128-134.
     PubMed     Text format     Abstract available
     
     
     
111. STOLLBERGER C, Finsterer J, Schneider B
     Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
     Int J Cardiol. 2016;216:186-187.
     PubMed     Text format    
     
     
     
112. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
     Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
     Int J Cardiol. 2016;215:11-13.
     PubMed     Text format    
     
     
     
113. XIE XX, Liu P, Wan FY, Lin SG, et al
     Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
     Int J Cardiol. 2016;208:141-6.
     PubMed     Text format    
     
     
     March 2016
114. KOUNIS NG, Grapsas N, Soufras GD, Lianas D, et al
     Clinical and subclinical leaflet thrombosis in bioprosthetic aortic valves: A manifestation of Kounis syndrome?
     Int J Cardiol. 2016;214:86-87.
     PubMed     Text format    
     
     
     
115. EFTEKHARI A, Damgaard D, Grove EL
     Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
     Int J Cardiol. 2016;214:131-132.
     PubMed     Text format    
     
     
     
116. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
     Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
     Int J Cardiol. 2016;212:311-317.
     PubMed     Text format     Abstract available
     
     
     
117. COLEMAN CI, Tangirala M, Evers T
     Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
     Int J Cardiol. 2016;212:171-173.
     PubMed     Text format    
     
     
     
118. TONG Y, Huang X, Wang Z, Han S, et al
     Effects of functional genetic variants in PPARdelta encoding peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in Chinese Han population.
     Int J Cardiol. 2016;207:297-9.
     PubMed     Text format    
     
     
     
119. DELLBORG M, Eriksson P
     Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
     Int J Cardiol. 2016;207:308-9.
     PubMed     Text format    
     
     
     February 2016
120. YIP HK, Yuen CM, Chen KH, Chai HT, et al
     Tissue plasminogen activator deficiency preserves neurological function and protects against murine acute ischemic stroke.
     Int J Cardiol. 2016;205:133-41.
     PubMed     Text format     Abstract available
     
     
     
121. SEO WK, Kang SH, Jung JM, Choi JY, et al
     Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
     Int J Cardiol. 2016;209:184-189.
     PubMed     Text format     Abstract available
     
     
     
122. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
     Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
     Int J Cardiol. 2016;209:1-6.
     PubMed     Text format     Abstract available
     
     
     
123. LEE YB, Jeong SW, Rhee MY, Leem CH, et al
     Aorta-to-arm pulse wave transit time ratio: Better prediction of coronary artery disease and stroke than pulse wave velocity.
     Int J Cardiol. 2016;204:1-3.
     PubMed     Text format    
     
     
     January 2016
124. CHHABRA L
     Importance of P-wave indices in stroke.
     Int J Cardiol. 2016;203:962-3.
     PubMed     Text format    
     
     
     
125. LEE YJ, Park JK, Uhm JS, Kim JY, et al
     Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
     Int J Cardiol. 2016;203:372-8.
     PubMed     Text format     Abstract available
     
     
     
126. KEFER J, Tzikas A, Freixa X, Shakir S, et al
     Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
     Int J Cardiol. 2016;207:335-340.
     PubMed     Text format     Abstract available
     
     
     
127. PANG J, Zhang Z, Zheng TZ, Bassig BA, et al
     Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.
     Int J Cardiol. 2016;202:967-74.
     PubMed     Text format     Abstract available
     
     
     
128. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
     Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
     Int J Cardiol. 2016;202:578-85.
     PubMed     Text format     Abstract available
     
     
     December 2015
129. CHEN YL, Tsai TH, Wallace CG, Chen YL, et al
     Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats.
     Int J Cardiol. 2015;201:668-83.
     PubMed     Text format     Abstract available
     
     
     
130. KANAI M, Kubo H, Kitamura Y, Izawa KP, et al
     Difference in autonomic nervous activity in different subtypes of noncardioembolic ischemic stroke.
     Int J Cardiol. 2015;201:171-3.
     PubMed     Text format    
     
     
     
131. GUO X, Li Z, Sun G, Guo L, et al
     Comparison of four nontraditional lipid profiles in relation to ischemic stroke among hypertensive Chinese population.
     Int J Cardiol. 2015;201:123-5.
     PubMed     Text format    
     
     
     
132. TIAN L, Qiu H, Pun VC, Ho KF, et al
     Carbon monoxide and stroke: A time series study of ambient air pollution and emergency hospitalizations.
     Int J Cardiol. 2015;201:4-9.
     PubMed     Text format     Abstract available
     
     
     November 2015
133. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
     Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
     Int J Cardiol. 2015;203:906-908.
     PubMed     Text format    
     
     
     
134. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
     Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
     Int J Cardiol. 2015;203:1014-1015.
     PubMed     Text format    
     
     
     
135. KONNO S, Munakata M
     High-density lipoprotein cholesterol might be a better predictor of stroke than other lipid measures in the general Japanese population: The Watari study.
     Int J Cardiol. 2015;203:874-876.
     PubMed     Text format    
     
     
     
136. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
     A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
     Int J Cardiol. 2015;203:785-790.
     PubMed     Text format     Abstract available
     
     
     
137. YANG Y, Liu Q, Wu Z, Li X, et al
     Is hyperuricemia a recognizable biomarker for low risk of stroke in patients with atrial fibrillation?
     Int J Cardiol. 2015;203:624-625.
     PubMed     Text format    
     
     
     
138. PIRINEN J, Putaala J, Aro AL, Surakka I, et al
     Resting 12-lead electrocardiogram reveals high-risk sources of cardioembolism in young adult ischemic stroke.
     Int J Cardiol. 2015;198:196-200.
     PubMed     Text format     Abstract available
     
     
     October 2015
139. EYUBOGLU M
     Inadequate anticoagulation by Vitamin K antagonists and major adverse cardiovascular events other than stroke.
     Int J Cardiol. 2015 Oct 30. pii: S0167-5273(15)30553.
     PubMed     Text format    
     
     
     
140. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
     Strokes after cardioversion of atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2015;203:269-273.
     PubMed     Text format    
     
     
     
141. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
     New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
     Int J Cardiol. 2015;203:264-266.
     PubMed     Text format    
     
     
     
142. LIN YS, Tung TH, Wang J, Chen YF, et al
     Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
     Int J Cardiol. 2015;203:204-211.
     PubMed     Text format     Abstract available
     
     
     
143. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
     Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".
     Int J Cardiol. 2015 Oct 17. pii: S0167-5273(15)30687.
     PubMed     Text format    
     
     
     
144. ZHOU X, Zhang W, Lv W, Zhou Q, et al
     Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
     Int J Cardiol. 2015;203:55-59.
     PubMed     Text format     Abstract available
     
     
     
145. HUANG H, Zeng J, Kang Y, Huang H, et al
     Acute ischemia stroke: A rare and severe complication of ovarian hyperstimulation syndrome.
     Int J Cardiol. 2015;203:418-419.
     PubMed     Text format    
     
     
     
146. BAIN LK, Myint PK, Jennings A, Lentjes MA, et al
     The relationship between dietary magnesium intake, stroke and its major risk factors, blood pressure and cholesterol, in the EPIC-Norfolk cohort.
     Int J Cardiol. 2015;196:108-14.
     PubMed     Text format     Abstract available
     
     
     September 2015
147. ERGELEN M, Uyarel H, Goktekin O
     Interventional cardiologists in the treatment of acute ischemic stroke: New players in the game.
     Int J Cardiol. 2015;202:674-675.
     PubMed     Text format    
     
     
     
148. KIM H, Ryu DR
     Difference in stroke incidence between Korean and Japanese patients initiating dialysis - era or ethnic effect?
     Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30397.
     PubMed     Text format    
     
     
     
149. NOZOE M, Kitamura Y, Kanai M, Kubo H, et al
     Physical activity in acute ischemic stroke patients during hospitalization.
     Int J Cardiol. 2015;202:624-626.
     PubMed     Text format    
     
     
     
150. KAWADA T
     Risk of major cardiovascular events in patients with hemodialysis or peritoneal dialysis with special reference to stroke.
     Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30302.
     PubMed     Text format    
     
     
     
151. COLEMAN CI, Antz M, Ehlken B, Evers T, et al
     REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation - The RELIEF study.
     Int J Cardiol. 2015;203:882-884.
     PubMed     Text format    
     
     
     
152. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
     Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
     Int J Cardiol. 2015;202:589-594.
     PubMed     Text format     Abstract available
     
     
     
153. MIRZADA N, Ladenvall P, Hansson PO, Eriksson P, et al
     Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
     Int J Cardiol. 2015;195:293-9.
     PubMed     Text format     Abstract available
     
     
     
154. KUMAR N, Venkatraman A, Garg N
     Seasonality in acute ischemic stroke related hospitalizations and case fatality rate in the United States.
     Int J Cardiol. 2015;195:134-5.
     PubMed     Text format    
     
     
     
155. AHMAD Y, Nijjer S, Cook CM, El-Harasis M, et al
     A new method of applying randomised control study data to the individual patient: A novel quantitative patient-centred approach to interpreting composite end points.
     Int J Cardiol. 2015;195:216-24.
     PubMed     Text format     Abstract available
     
     
     August 2015
156. YUAN M, Zhou HY, Xiao XL, Wang ZQ, et al
     Inflammatory bowel disease and risk of stroke: A meta-analysis of cohort studies.
     Int J Cardiol. 2015;202:106-109.
     PubMed     Text format    
     
     
     
157. BLANN AD, Banerjee A, Lane DA, Torp-Pedersen C, et al
     Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study.
     Int J Cardiol. 2015;201:693-698.
     PubMed     Text format     Abstract available
     
     
     
158. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
     Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
     Int J Cardiol. 2015;201:513-516.
     PubMed     Text format     Abstract available
     
     
     
159. PENG H, Chen M, Li G, Zhang M, et al
     Combination refusion therapy for a hemodynamically unstable patient with acute myocardial infarction complicated by acute ischemic stroke within a time window.
     Int J Cardiol. 2015;201:152-153.
     PubMed     Text format    
     
     
     
160. CHENG CL, Chien HC, Lee CH, Lin SJ, et al
     Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan.
     Int J Cardiol. 2015;201:96-101.
     PubMed     Text format     Abstract available
     
     
     July 2015
161. BATUROVA MA, Lindgren A, Carlson J, Shubik YV, et al
     Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
     Int J Cardiol. 2015;199:248-252.
     PubMed     Text format     Abstract available
     
     
     
162. XU T, Ke K
     C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies.
     Int J Cardiol. 2015;190:264-7.
     PubMed     Text format    
     
     
     
163. TONG Y, Lu Q, Zhang Y, Zhan F, et al
     Association of functional genetic variants in PPARgamma and PPARalpha encoding peroxisome proliferator-activated receptors with ischemic stroke in a unique Chinese population.
     Int J Cardiol. 2015;190:205-7.
     PubMed     Text format    
     
     
     
164. ACAMPA M, Guideri F, Tassi R, Dello Buono D, et al
     P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
     Int J Cardiol. 2015;190:202-4.
     PubMed     Text format    
     
     
     June 2015
165. LAI HC, Chien WC, Chung CH, Lee WL, et al
     Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study.
     Int J Cardiol. 2015;197:133-139.
     PubMed     Text format     Abstract available
     
     
     
166. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
     Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
     Int J Cardiol. 2015;189:247-8.
     PubMed     Text format    
     
     
     
167. AGARWAL S, Parashar A, Kumbhani DJ, Svensson LG, et al
     Comparative meta-analysis of balloon-expandable and self-expandable valves for transcatheter aortic valve replacement.
     Int J Cardiol. 2015;197:87-97.
     PubMed     Text format     Abstract available
     
     
     
168. LASEK-BAL A, Gasior Z, Kowalewska-Twardela T, Urbanek T, et al
     New-onset atrial fibrillation in patients with elevated troponin I levels in the acute phase of stroke.
     Int J Cardiol. 2015;195:210-211.
     PubMed     Text format    
     
     
     May 2015
169. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
     Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?
     Int J Cardiol. 2015;196:53.
     PubMed     Text format    
     
     
     
170. BRAMBATTI M, Darius H, Oldgren J, Clemens A, et al
     Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
     Int J Cardiol. 2015;196:127-131.
     PubMed     Text format     Abstract available
     
     
     
171. XIONG Q, Chen S, Senoo K, Proietti M, et al
     The CHADS and CHADS-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis.
     Int J Cardiol. 2015;195:237-242.
     PubMed     Text format     Abstract available
     
     
     
172. LOSI MA, Izzo R, Stabile E, Sannino A, et al
     Diastolic dysfunction reduces stroke volume during daily's life activities in patients with severe aortic stenosis.
     Int J Cardiol. 2015;195:64-65.
     PubMed     Text format    
     
     
     
173. POTLURI R, Wasim M, Markandey B, Kapour A, et al
     Length of hospital stay is shorter in South Asian patients with ischaemic stroke.
     Int J Cardiol. 2015;187:190-1.
     PubMed     Text format    
     
     
     
174. WONG K, Sze S, Wong S, McSwiggan S, et al
     Myocardial fibrosis in stroke survivors.
     Int J Cardiol. 2015;187:138-40.
     PubMed     Text format    
     
     
     
175. HURLEY C, Dai S, Sobieraj DM
     The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naive, new-onset nonvalvular atrial fibrillation.
     Int J Cardiol. 2015;192:1-2.
     PubMed     Text format    
     
     
     April 2015
176. STERLING LH, Windle SB, Filion KB, Eisenberg MJ, et al
     Pharmacological management strategies for stroke prevention following transcatheter aortic valve replacement: A systematic review.
     Int J Cardiol. 2015;191:303-311.
     PubMed     Text format     Abstract available
     
     
     
177. HSU CW, Huang YB, Chen CY
     Effect of antithrombotic and antiplatelet agents for ischemic stroke in atrial fibrillation patients with dialysis.
     Int J Cardiol. 2015;190:349.
     PubMed     Text format    
     
     
     
178. LI M, Li K, Zhang XW, Hou WS, et al
     Habitual snoring and risk of stroke: A meta-analysis of prospective studies.
     Int J Cardiol. 2015;185:46-9.
     PubMed     Text format    
     
     
     
179. WANG J, Gu C, Gao M, Yu W, et al
     Comparison of the incidence of postoperative neurologic complications after on-pump versus off-pump coronary artery bypass grafting in high-risk patients: A meta-analysis of 11 studies.
     Int J Cardiol. 2015;185:195-7.
     PubMed     Text format    
     
     
     
180. MOSCHONAS IC, Goudevenos JA, Tselepis AD
     Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives.
     Int J Cardiol. 2015;185:9-18.
     PubMed     Text format     Abstract available
     
     
     
181. VAN DOORN S, Hartman-Weide F, Geersing GJ, Oudega R, et al
     Reasons for non-adherence to practice guidelines on stroke prevention in patients with atrial fibrillation: A cross-sectional study in primary care.
     Int J Cardiol. 2015;187:525-526.
     PubMed     Text format    
     
     
     
182. YILDIZ A, Soydinc S
     Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
     Int J Cardiol. 2015;184:512-3.
     PubMed     Text format    
     
     
     
183. FINSTERER J, Zarrouk-Mahjoub S
     Management of juvenile stroke from noncompaction with muscular dystrophy.
     Int J Cardiol. 2015;184:371-2.
     PubMed     Text format    
     
     
     
184. LI M, Zhang Z, Chen Y
     A comparison of stroke and coronary risks in Chinese and American.
     Int J Cardiol. 2015;184:251-3.
     PubMed     Text format    
     
     
     
185. ZHANG E, Liu T, Li Z, Zhao J, et al
     High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography.
     Int J Cardiol. 2015;184:540-2.
     PubMed     Text format    
     
     
     
186. CARLSSON AC, Wandell P, Gasevic D, Sundquist J, et al
     Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
     Int J Cardiol. 2015;187:547-552.
     PubMed     Text format     Abstract available
     
     
     March 2015
187. RUNEV NM, Dimitrov SM
     Management of stroke prevention in Bulgarian patients with non-valvular atrial fibrillation (BUL-AF Survey).
     Int J Cardiol. 2015;187:683-685.
     PubMed     Text format    
     
     
     
188. CHEN CH, Chen MC, Gibbs H, Kwon SU, et al
     Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda.
     Int J Cardiol. 2015;191:244-253.
     PubMed     Text format     Abstract available
     
     
     
189. NAIROOZ R, Sardar P, Pino M, Aronow WS, et al
     Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
     Int J Cardiol. 2015;187:345-353.
     PubMed     Text format     Abstract available
     
     
     
190. LIN HJ, Chen ST, Wu HY, Hsu HC, et al
     Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: a nested case-control study from a community-based cohort.
     Int J Cardiol. 2015;183:214-20.
     PubMed     Text format     Abstract available
     
     
     
191. O'NEAL WT, Tanner RM, Efird JT, Baber U, et al
     Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
     Int J Cardiol. 2015;185:219-223.
     PubMed     Text format     Abstract available
     
     
     
192. DENTALI F, Botto GL, Gianni M, Ambrosino P, et al
     Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature.
     Int J Cardiol. 2015;185:72-77.
     PubMed     Text format     Abstract available
     
     
     
193. WONG CX, Lee SW, Gan SW, Mahajan R, et al
     Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians.
     Int J Cardiol. 2015;191:20-24.
     PubMed     Text format     Abstract available
     
     
     
194. MCCALL SJ, Musgrave SD, Potter JF, Hale R, et al
     The shock index predicts acute mortality outcomes in stroke.
     Int J Cardiol. 2015;182:523-7.
     PubMed     Text format     Abstract available
     
     
     
195. WANG J, Gu C, Gao M, Yu W, et al
     Adjunct coronary endarterectomy increases cerebrovascular accident after coronary artery bypass grafting: a meta-analysis of 17,600 patients.
     Int J Cardiol. 2015;182:79-81.
     PubMed     Text format    
     
     
     February 2015
196. SZYMANSKI FM, Platek AE, Filipiak KJ
     Is obstructive sleep apnea associated with the risk of ischemic stroke in patients with atrial fibrillation?
     Int J Cardiol. 2015;184:481-482.
     PubMed     Text format    
     
     
     
197. KALEMCI S, Altun I, Akin F, Biteker M, et al
     Obstructive sleep apnea and stroke risk in atrial fibrillation: Is there a correlation or not?
     Int J Cardiol. 2015;184C:306.
     PubMed     Text format    
     
     
     
198. NOWAK R, Jaguszewski M, Fijalkowski M, Fijalkowska M, et al
     CMR to distinguish Takotsubo cardiomyopathy from myocardial infarction in acute course of ischemic stroke in a male patient.
     Int J Cardiol. 2015;184C:397-398.
     PubMed     Text format    
     
     
     
199. SENOO K, Lane DA, Lip GY
     Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
     Int J Cardiol. 2015;181:247-54.
     PubMed     Text format     Abstract available
     
     
     
200. KRAL M, Sanak D, Veverka T, Hutyra M, et al
     Troponin T: Correlation with location and volume of acute brain infarction.
     Int J Cardiol. 2015;181:127-32.
     PubMed     Text format     Abstract available
     
     
     January 2015
201. RAPOSEIRAS-ROUBIN S, Garcia-Seara J, Cabanas-Grandio P, Abu-Assi E, et al
     Is safe to discontinue anticoagulation after successful ablation of atrial flutter?
     Int J Cardiol. 2015;201:631-632.
     PubMed     Text format    
     
     
     
202. WINKEL P, Hilden J, Hansen JF, Kastrup J, et al
     Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
     Int J Cardiol. 2015;182C:459-465.
     PubMed     Text format     Abstract available
     
     
     
203. MENON J, Vijayakumar N, Joseph JK, David PC, et al
     Below the poverty line and non-communicable diseases in Kerala: The Epidemiology of Non-communicable Diseases in Rural Areas (ENDIRA) study.
     Int J Cardiol. 2015;187:519-24.
     PubMed     Text format     Abstract available
     
     
     December 2014
204. CHANG CC, Chiu CC, Chiang CH, Huang CC, et al
     Obstructive sleep apnea and the risk of ischemic stroke in patients with atrial fibrillation.
     Int J Cardiol. 2014;181C:144-146.
     PubMed     Text format    
     
     
     November 2014
205. LIP GY, Wang KL, Chiang CE
     Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal.
     Int J Cardiol. 2014;180C:246-254.
     PubMed     Text format     Abstract available
     
     
     
206. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
     Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
     Int J Cardiol. 2014;180C:1-5.
     PubMed     Text format     Abstract available
     
     
     
207. YEH PS, Yang CM, Lin SH, Wang WM, et al
     Antithrombotic therapy for atrial fibrillation in patients with acute ischemic stroke or transient ischemic attack.
     Int J Cardiol. 2014;179C:288-291.
     PubMed     Text format    
     
     
     
208. KORNEJ J, Lobe S, Efimova E, Husser D, et al
     NT-proBNP in "low risk" patients with atrial fibrillation.
     Int J Cardiol. 2014 Nov 6. pii: S0167-5273(14)02188.
     PubMed     Text format    
     
     
     October 2014
209. VASSILIOU V, Rana B, Goddard M, Braganza D, et al
     Acute myocardial infarction and acute stroke: Between a rock and a hard place.
     Int J Cardiol. 2014;180C:214-215.
     PubMed     Text format    
     
     
     
210. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
     Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation-A nation-wide database analyses.
     Int J Cardiol. 2014;177:1008-1011.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: